Brandinium

Trademark search for:

ORYX PHARMACEUTICALS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2002-04-17 — Application filed
  • 2002-08-09 — Assigned to examiner
  • 2002-08-13 — Final disposition recorded
  • 2003-02-20 — Paper received
  • 2003-02-20 — Correspondence received in law office
  • 2003-03-21 — Letter of suspension mailed
  • 2003-11-17 — Case file in ticrs
  • 2004-01-13 — Inquiry as to suspension mailed
  • 2004-06-21 — Paper received
  • 2004-06-21 — Correspondence received in law office
  • 2004-06-21 — Amendment from applicant entered
  • 2004-07-08 — Letter of suspension mailed
  • 2005-01-10 — Suspension checked - to attorney for action
  • 2005-01-24 — Suspension inquiry written
  • 2005-01-24 — Approved for pub - principal register
  • 2005-01-24 — Previous allowance count withdrawn
  • 2005-07-25 — Paper received
  • 2005-07-25 — Correspondence received in law office
  • 2005-08-03 — Amendment from applicant entered
  • 2005-08-10 — Suspension letter written
  • 2005-08-11 — Letter of suspension mailed
  • 2005-09-06 — Paper received
  • 2005-10-19 — Undeliverable mail - no action taken
  • 2006-02-22 — Suspension inquiry written
  • 2006-02-22 — Inquiry as to suspension mailed
  • 2006-03-20 — Paper received
  • 2006-03-20 — Correspondence received in law office
  • 2006-04-04 — Amendment from applicant entered
  • 2006-04-24 — Approved for pub - principal register
  • 2006-04-28 — Assigned to lie
  • 2006-05-02 — Law office publication review completed
  • 2006-05-31 — Notice of publication
  • 2006-06-20 — Published for opposition
  • 2006-07-19 — Extension of time to oppose received
  • 2006-11-03 — Extension of time to oppose process - terminated
  • 2006-11-15 — Opposition instituted no. 999999
  • 2008-10-29 — Opposition sustained no. 999999
  • 2008-10-29 — Opposition terminated no. 999999
  • 2008-10-29 — Application abandoned
  • 2008-10-29 — Application abandoned
  • 2008-10-29 — Final status recorded

Owner Information

Oryx Pharmaceuticals Inc.
Mississauga, Ontario, L5N 2B8 CA
Oryx Pharmaceuticals Inc.
Mississauga, Ontario, L5N 2B8 CA

Correspondent

Connie L Ellerbach FENWICK & WEST LLP
801 California St
Silicon Valley Ctr
Mountain View, CA 94041

Filing Details

Filing Date:
2002-04-17
Status Date:
2008-10-29
Category:
Pharmaceuticals
Filing Year:
2002

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.